Genmab AS

Genmab AS Fixed Asset Turnover

The Fixed Asset Turnover of Genmab AS (GMAB) as of Nov 22, 2026 is 10.97. In the previous year, Fixed Asset Turnover was 8.63 — a change of 27.10% (higher).

Fixed Asset Turnover

10.97

YoY

27.10%

Last updated:

Fixed Asset Turnover of Genmab AS is 2022 10.97 . Fixed Asset Turnover of Genmab AS was 2021 8.63 . It decreases by 27.10% higher compared to the previous year.

The Genmab AS Fixed Asset Turnover history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

Fixed Asset Turnover
Date
Fixed Asset Turnover
Jan 1, 2015
39.33 USD
Jan 1, 2016
56.41 USD
Jan 1, 2017
20.86 USD
Jan 1, 2018
18.67 USD
Jan 1, 2019
12.96 USD
Jan 1, 2020
13.74 USD
Jan 1, 2021
8.63 USD
Jan 1, 2022
10.97 USD
The Genmab AS Fixed Asset Turnover history
YEARFixed Asset TurnoverYoY
10.97+27.10%
8.63-37.16%
13.74+5.99%
12.96-30.59%
18.67-10.47%
20.86-63.03%
56.41+43.45%
39.33—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Genmab AS Stock analysis

What does Genmab AS do? Genmab AS is a biotechnology company based in Copenhagen, Denmark, operating in the Health Care sector. It develops and markets antibody-based therapies for cancer and other diseases, including EPKINLY, TEPKINLY, and Tivdak for various lymphomas and cervical cancer. The company also advances several product candidates in clinical development, such as Epcoritamab for lymphomas and GEN1059 for solid tumors, alongside established treatments like DARZALEX and TECVAYLI for multiple myeloma and other conditions. Genmab AS is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Genmab AS stock

Fixed Asset Turnover of Genmab AS is 10.97 in 2022.

Fixed Asset Turnover of Genmab AS changed from 8.63 to 10.97, representing a 27.10% change. The value is higher than the previous year.

On Eulerpool you can find the complete historical development of Fixed Asset Turnover Genmab AS since 2006 – with annual values, charts, and detailed analysis.

Fixed asset turnover measures revenue generated per unit of PP&E. Higher ratios indicate more efficient utilization of physical assets.

A 'good' varies by industry and company stage. On Eulerpool, you can compare Fixed Asset Turnover's Genmab AS with sector peers and the industry average to assess whether it is attractive.

To evaluate Fixed Asset Turnover's, it is essential to compare it with peers in the same industry and sector. On Eulerpool, you can find direct industry comparisons for Fixed Asset Turnover.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Profitability — Genmab AS

All Key Metrics — Genmab AS